Summary of Workshop on Use of Data Developed during Drug Development for Read across to Environmental Analyses
The chemistry; primary and secondary pharmacodynamics (eg, mechanism of action and pharmacological actions unrelated to the therapeutic effect); pharmacokinetics (absorption, distribution, metabolism, and excretion); and in vitro and animal toxicology of human pharmaceuticals are extensively studied...
Gespeichert in:
| Veröffentlicht in: | Drug information journal 2007-03, Vol.41 (2), p.201-202 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 202 |
|---|---|
| container_issue | 2 |
| container_start_page | 201 |
| container_title | Drug information journal |
| container_volume | 41 |
| creator | Olejniczak, Klaus Williams, Richard T. Kühler, Thomas Spindler, Per |
| description | The chemistry; primary and secondary pharmacodynamics (eg, mechanism of action and pharmacological actions unrelated to the therapeutic effect); pharmacokinetics (absorption, distribution, metabolism, and excretion); and in vitro and animal toxicology of human pharmaceuticals are extensively studied during preregistration discovery and development. [...] utilizing data that support the medical use of a pharmaceutical to answer environmental questions or guide the development of environmental data has potential benefits that include minimizing (eg, not duplicating) animal testing and enhancing the focus and effectiveness of the environmental risk assessment. |
| doi_str_mv | 10.1177/009286150704100212 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_275165696</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_009286150704100212</sage_id><sourcerecordid>1246367201</sourcerecordid><originalsourceid>FETCH-LOGICAL-c293t-3309d7ad6f8883a37963a0e4ac1c3df1933afeb91c5c1c7e6f163ab6672e7f9b3</originalsourceid><addsrcrecordid>eNp9kN1LwzAUxYMoOKf_gE9Bn-vy0SbN49jmBwiCOnwsWXszN7ukJu1g_72pU3wQfbpw7u8c7j0InVNyRamUI0IUywXNiCQpJYRRdoAGjIo0UYyQQzTogaQnjtFJCOuIEJaqAbJP3Waj_Q47g1-cfwuvrsHO4nmAXprqVuMpbKF2DVS46vzKLvHUd8tvdQO2xcZ5_Ai6wrr0LgTcOjyz25V3tl_rGo-trncBwik6MroOcPY1h2h-PXue3Cb3Dzd3k_F9UjLF24RzoiqpK2HyPOeaSyW4JpDqkpa8MlRxrg0sFC2zqEgQhkZgIYRkII1a8CG62Oc23r13ENpi7TofjwgFkxkVmYiJQ3T5J5TGKmVOSBYptqc-X_Ngisav-soKSoq-_OJ3-dE02puCXsJP7D-OD1mIg-s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>275165696</pqid></control><display><type>article</type><title>Summary of Workshop on Use of Data Developed during Drug Development for Read across to Environmental Analyses</title><source>Access via SAGE</source><source>SpringerLink Journals</source><creator>Olejniczak, Klaus ; Williams, Richard T. ; Kühler, Thomas ; Spindler, Per</creator><creatorcontrib>Olejniczak, Klaus ; Williams, Richard T. ; Kühler, Thomas ; Spindler, Per</creatorcontrib><description>The chemistry; primary and secondary pharmacodynamics (eg, mechanism of action and pharmacological actions unrelated to the therapeutic effect); pharmacokinetics (absorption, distribution, metabolism, and excretion); and in vitro and animal toxicology of human pharmaceuticals are extensively studied during preregistration discovery and development. [...] utilizing data that support the medical use of a pharmaceutical to answer environmental questions or guide the development of environmental data has potential benefits that include minimizing (eg, not duplicating) animal testing and enhancing the focus and effectiveness of the environmental risk assessment.</description><identifier>ISSN: 0092-8615</identifier><identifier>ISSN: 2168-4790</identifier><identifier>EISSN: 2164-9200</identifier><identifier>EISSN: 2168-4804</identifier><identifier>DOI: 10.1177/009286150704100212</identifier><identifier>CODEN: DGIJB9</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Drug development ; Environmental impact ; Pharmaceutical industry ; Risk assessment ; Workshops</subject><ispartof>Drug information journal, 2007-03, Vol.41 (2), p.201-202</ispartof><rights>2007 Drug Information Association</rights><rights>Drug Information Association, Inc 2007.</rights><rights>Copyright Drug Information Association 2007</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/009286150704100212$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/009286150704100212$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,21819,27924,27925,43621,43622</link.rule.ids></links><search><creatorcontrib>Olejniczak, Klaus</creatorcontrib><creatorcontrib>Williams, Richard T.</creatorcontrib><creatorcontrib>Kühler, Thomas</creatorcontrib><creatorcontrib>Spindler, Per</creatorcontrib><title>Summary of Workshop on Use of Data Developed during Drug Development for Read across to Environmental Analyses</title><title>Drug information journal</title><description>The chemistry; primary and secondary pharmacodynamics (eg, mechanism of action and pharmacological actions unrelated to the therapeutic effect); pharmacokinetics (absorption, distribution, metabolism, and excretion); and in vitro and animal toxicology of human pharmaceuticals are extensively studied during preregistration discovery and development. [...] utilizing data that support the medical use of a pharmaceutical to answer environmental questions or guide the development of environmental data has potential benefits that include minimizing (eg, not duplicating) animal testing and enhancing the focus and effectiveness of the environmental risk assessment.</description><subject>Drug development</subject><subject>Environmental impact</subject><subject>Pharmaceutical industry</subject><subject>Risk assessment</subject><subject>Workshops</subject><issn>0092-8615</issn><issn>2168-4790</issn><issn>2164-9200</issn><issn>2168-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kN1LwzAUxYMoOKf_gE9Bn-vy0SbN49jmBwiCOnwsWXszN7ukJu1g_72pU3wQfbpw7u8c7j0InVNyRamUI0IUywXNiCQpJYRRdoAGjIo0UYyQQzTogaQnjtFJCOuIEJaqAbJP3Waj_Q47g1-cfwuvrsHO4nmAXprqVuMpbKF2DVS46vzKLvHUd8tvdQO2xcZ5_Ai6wrr0LgTcOjyz25V3tl_rGo-trncBwik6MroOcPY1h2h-PXue3Cb3Dzd3k_F9UjLF24RzoiqpK2HyPOeaSyW4JpDqkpa8MlRxrg0sFC2zqEgQhkZgIYRkII1a8CG62Oc23r13ENpi7TofjwgFkxkVmYiJQ3T5J5TGKmVOSBYptqc-X_Ngisav-soKSoq-_OJ3-dE02puCXsJP7D-OD1mIg-s</recordid><startdate>200703</startdate><enddate>200703</enddate><creator>Olejniczak, Klaus</creator><creator>Williams, Richard T.</creator><creator>Kühler, Thomas</creator><creator>Spindler, Per</creator><general>SAGE Publications</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope></search><sort><creationdate>200703</creationdate><title>Summary of Workshop on Use of Data Developed during Drug Development for Read across to Environmental Analyses</title><author>Olejniczak, Klaus ; Williams, Richard T. ; Kühler, Thomas ; Spindler, Per</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c293t-3309d7ad6f8883a37963a0e4ac1c3df1933afeb91c5c1c7e6f163ab6672e7f9b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Drug development</topic><topic>Environmental impact</topic><topic>Pharmaceutical industry</topic><topic>Risk assessment</topic><topic>Workshops</topic><toplevel>online_resources</toplevel><creatorcontrib>Olejniczak, Klaus</creatorcontrib><creatorcontrib>Williams, Richard T.</creatorcontrib><creatorcontrib>Kühler, Thomas</creatorcontrib><creatorcontrib>Spindler, Per</creatorcontrib><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><jtitle>Drug information journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Olejniczak, Klaus</au><au>Williams, Richard T.</au><au>Kühler, Thomas</au><au>Spindler, Per</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Summary of Workshop on Use of Data Developed during Drug Development for Read across to Environmental Analyses</atitle><jtitle>Drug information journal</jtitle><date>2007-03</date><risdate>2007</risdate><volume>41</volume><issue>2</issue><spage>201</spage><epage>202</epage><pages>201-202</pages><issn>0092-8615</issn><issn>2168-4790</issn><eissn>2164-9200</eissn><eissn>2168-4804</eissn><coden>DGIJB9</coden><abstract>The chemistry; primary and secondary pharmacodynamics (eg, mechanism of action and pharmacological actions unrelated to the therapeutic effect); pharmacokinetics (absorption, distribution, metabolism, and excretion); and in vitro and animal toxicology of human pharmaceuticals are extensively studied during preregistration discovery and development. [...] utilizing data that support the medical use of a pharmaceutical to answer environmental questions or guide the development of environmental data has potential benefits that include minimizing (eg, not duplicating) animal testing and enhancing the focus and effectiveness of the environmental risk assessment.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><doi>10.1177/009286150704100212</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0092-8615 |
| ispartof | Drug information journal, 2007-03, Vol.41 (2), p.201-202 |
| issn | 0092-8615 2168-4790 2164-9200 2168-4804 |
| language | eng |
| recordid | cdi_proquest_journals_275165696 |
| source | Access via SAGE; SpringerLink Journals |
| subjects | Drug development Environmental impact Pharmaceutical industry Risk assessment Workshops |
| title | Summary of Workshop on Use of Data Developed during Drug Development for Read across to Environmental Analyses |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T07%3A57%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Summary%20of%20Workshop%20on%20Use%20of%20Data%20Developed%20during%20Drug%20Development%20for%20Read%20across%20to%20Environmental%20Analyses&rft.jtitle=Drug%20information%20journal&rft.au=Olejniczak,%20Klaus&rft.date=2007-03&rft.volume=41&rft.issue=2&rft.spage=201&rft.epage=202&rft.pages=201-202&rft.issn=0092-8615&rft.eissn=2164-9200&rft.coden=DGIJB9&rft_id=info:doi/10.1177/009286150704100212&rft_dat=%3Cproquest_cross%3E1246367201%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=275165696&rft_id=info:pmid/&rft_sage_id=10.1177_009286150704100212&rfr_iscdi=true |